نتائج البحث

1

دورية أكاديمية

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

المساهمون: D'agostino M., Cairns D.A., Lahuerta J.J., Wester R., Bertsch U., Waage A., Zamagni E., Mateos M.-V., Dall'olio D., Van De Donk N.W.C.J., Jackson G., Rocchi S., Salwender H., Blade Creixenti J., Van Der Holt B., Castellani G., Bonello F., Capra A., Mai E.K., Durig J., Gay F., Zweegman S., Cavo M., Kaiser M.F., Goldschmidt H., Hernandez Rivas J.M., Larocca A., Cook G., San-Miguel J.F., Boccadoro M., Sonneveld P.

مصطلحات موضوعية: Second Revision, International Staging System, R2-ISS, Overall Survival, Multiple Myeloma, EMN, HARMONY Project

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000864709100008; volume:364; issue:29; firstpage:3406; lastpage:3418; numberofpages:13; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11585/897453Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85132516085

الإتاحة: https://doi.org/10.1200/JCO.21.02614Test
https://hdl.handle.net/11585/897453Test

View record in BASE

2

دورية أكاديمية

P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA

المؤلفون: Huhn, S., Poos, A. M., Mai, E. K., Hänel, M., Salwender, H. J., Dürig, J., Blau, I. W., Scheid, C., Weisel, K. C., Munder, M., Berlanga, O., Bertsch, U., Goldschmidt, H., Weinhold, N.

المصدر: HemaSphere ; volume 6, page 771-772 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000846392.99356.dfTest

View record in BASE

3

دورية أكاديمية

P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL

المصدر: HemaSphere ; volume 6, page 820-821 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000846588.94000.04Test

View record in BASE

4

دورية أكاديمية

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients

المساهمون: Mai E.K., Hielscher T., Bertsch U., Salwender H.J., Zweegman S., Raab M.S., Munder M., Pantani L., Mancuso K., Brossart P., Beksac M., Blau I.W., Durig J., Besemer B., Fenk R., Reimer P., van der Holt B., Hanel M., von Metzler I., Graeven U., Muller-Tidow C., Boccadoro M., Scheid C., Dimopoulos M.A., Hillengass J., Weisel K.C., Cavo M., Sonneveld P., Goldschmidt H.

مصطلحات موضوعية: Predictors, early morbidity, mortality, newly diagnosed multiple myeloma

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38062124; volume:0; firstpage:1; lastpage:1; numberofpages:1; journal:LEUKEMIA; https://hdl.handle.net/11585/959641Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85178939087

الإتاحة: https://doi.org/10.1038/s41375-023-02105-6Test
https://hdl.handle.net/11585/959641Test

View record in BASE

5

دورية أكاديمية

Bortezomib before and after high-dose therapy in myeloma:Long-term results from the phase III HOVON-65/GMMGHD-4 trial

المصدر: Goldschmidt , H , Lokhorst , H M , Mai , E K , van der Holt , B , Blau , I W , Zweegman , S , Weisel , K C , Vellenga , E , Pfreundschuh , M , Kersten , M J , Scheid , C , Croockewit , S , Raymakers , R , Hose , D , Potamianou , A , Jauch , A , Hillengass , J , Stevens-Kroef , M , Raab , M S , Broijl , A , Lindemann , H W , Bos , G M J , ....

مصطلحات موضوعية: STEM-CELL TRANSPLANTATION, DIAGNOSED MULTIPLE-MYELOMA, 2ND PRIMARY MALIGNANCIES, RANDOMIZED-TRIAL, DEXAMETHASONE COMBINATION, INTERGROUPE FRANCOPHONE, MAINTENANCE TREATMENT, PLUS DEXAMETHASONE, STAGING SYSTEM, DELETION 17P